Ledger.Open graph →

SEC Form D · filed February 14, 2019

Recros Medica, Inc

Offering

$10.0M

Sold

$4.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David F. Hale · San Diego, CADirector Kathleen D. Scott · San Diego, CAExec Edward F. Knowlton, M.D · San Diego, CAExec · Director Cathy L. Mccarthy · San Diego, CADirector Milind K. Ambe, M.D · San Diego, CADirector Randall Lunn · LAGUNA HILLS, CAExec John L. Hadl · Los Angeles, CADirector Andrew Mills · ALISO VIEJO, CADirector Bernard P. Murphy · Seattle, WAExec · Director Gregory N. Martin · Los Angeles, CADirector Christoph J. Westphal · San Diego, CADirector Thomas A. Albright · San Diego, CAExec · Director Mark J. Kerslake · San Diego, CADirector Sirjang Tandon · SIMI VALLEY, CADirector Mark Padley · NEW YORK, NYExec Thomas J. Furphy · Sammamish, WAExec · Director William J. Leigh · Seattle, WADirector Obvious Ventures Management Ii, L.L.C · SAN FRANCISCO, CADirector Christoph J. Westphal · San Diego, CADirector Thomas A. Albright · San Diego, CAExec · Director Mark J. Kerslake · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗